Medigray
Medigray (Inversiones Oridama S.A.) is a Costa Rican family-owned pharmaceutical manufacturer founded in 1988 that develops, produces, and commercializes more than 60 pharmaceutical, OTC, cosmetic, medical-device, and disinfectant products, supplying CCSS public healthcare, domestic pharmacy networks, and export distributors in four additional countries.
- Company typePrivate
- Founded1988
- HeadquartersDesamparados, Costa Rica
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
Medigray firmographics
Firmographics- Name
- Medigray
- Legal name
- Inversiones Oridama S.A.
- Website
- https://medigray.com
- Company type
- Private
- Founded year
- 1988
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Medigray (Inversiones Oridama S.A.) is a Costa Rican family-owned pharmaceutical manufacturer founded in 1988 that develops, produces, and commercializes more than 60 pharmaceutical, OTC, cosmetic, medical-device, and disinfectant products, supplying CCSS public healthcare, domestic pharmacy networks, and export distributors in four additional countries.
- Ownership category
- akta.pro rank
Medigray industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
Keywords
Where Medigray is headquartered
LocationHeadquarters
- HQ city
- Desamparados
- HQ country
- Costa Rica
- HQ region
- Latin America
Offices1 record
Markets served
Medigray business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Pharmaceutical Product Sales: Revenue generated from developing, producing, and commercializing pharmaceutical products including prescription medications, OTC products, and cosmetics through direct institutional sales (CCSS public sector) and retail pharmacy distribution.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels1 record
Medigray product offering
Product offeringCore offering
Medigray is a Costa Rican pharmaceutical manufacturer that develops, produces, and commercializes a portfolio of more than 60 differentiated medications and cosmetics across therapeutic categories including respiratory, pain, dermatology, gastrointestinal, antiparasitic, cardiometabolic, urological, vascular, and high-level disinfection. Products are sold through direct institutional sales to the CCSS public healthcare system, pharmacy retail networks in Costa Rica, and export distribution to four additional countries in Central America and the Caribbean.
Product overview
Medigray is a Costa Rican pharmaceutical company (founded 1988) that develops, produces, and commercializes pharmaceutical products and cosmetics. The product portfolio spans multiple therapeutic categories: Respiratory (Salbutín, Aquanasal, Herbatos), Pain/Anti-inflammatory (Megalivia, Golparén, Rolomed, Lidocaína Spray), Dermatological (Trofodermax, Biopantenol, Terminafín, Secaride, Fusicobiotic, Sport Ice), Gastric/Intestinal (Liviosan, Frutadex, Diabedex, Buco Vac), Urological (Urofos, Vigor, Vascumed), Antiparasitic (Piofín, Iverpiofin, Delix), Cardiometabolic (Diabecontrol, Ydrat), Multivitamins (IV Infusion), and High-Level Disinfectants (Ortoftaldehído, Glutaraldehído, Reactive Strips). The company also offers OTC products (Spin Deodorant, Otocerum, Lubrisex, Durasex, Aftotex, Alergel). Medigray exports to multiple countries including Dominican Republic, Panama, Peru, and El Salvador.
Differentiator
Problem solved
Functional benefit
Companies that use Medigray
Customer profileSegments3 records
Ideal customer profiles3 records
Medigray technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Medigray partnerships and signals
Strategic signalScale indicators3 records
Recent moves9 records
Expansion highlights4 records
Medigray competitors and assessment
Company assessmentDirect peers
- Eurofarma Laboratórios: Brazilian pharmaceutical manufacturer with operations across Latin America. Comparable as a Latin American pharma manufacturer with a diversified therapeutic portfolio and regional expansion strategy.
- Procaps S.A. Colombian pharmaceutical manufacturer with international presence across the Americas. Comparable as a regional branded pharma manufacturer with multi-country distribution and similar therapeutic-category breadth.
- Laboratorios Asofarma: Mexican pharmaceutical company focused on specialty pharma across Latin America. Comparable as a regional branded pharmaceutical manufacturer with presence in Central American and Latin American markets.
- Genomma Lab Internacional: Mexican pharmaceutical and personal care company focused on branded OTC products across Latin America. Highly comparable business model of developing and commercializing branded pharmaceutical and OTC products for Latin American markets.
- Laboratorios Roemmers: Argentine pharmaceutical manufacturer with regional presence across Latin America. Comparable as a regional pharmaceutical manufacturer with diversified product portfolio and multi-country footprint.
Broad incumbents
- Sanofi: Global pharmaceutical company with established Latin American operations. Operates broadly in the same therapeutic categories as Medigray but at much larger scale with deeper R&D and regulatory resources.
- Pfizer: Global pharmaceutical incumbent with established presence across Latin America. Overlaps in anti-infectives, cardiometabolic, and dermatology but at much larger scale and with proprietary IP.
- Bayer: Global pharmaceutical and life sciences company with extensive Latin American presence. Overlaps in OTC, cardiometabolic, and dermatology but as part of a much broader global portfolio.
- Teva Pharmaceutical Industries: Global generic and specialty pharmaceutical company. Operates in the same branded-generic space as Medigray but at vastly greater scale with a global manufacturing footprint.
Regional players
- Farmindustria S.A. Peruvian pharmaceutical manufacturer with regional presence. Comparable because Medigray already exports to Peru and operates in similar therapeutic categories; serves as a regional reference for Andean market dynamics.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Medigray financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medigray leadership team
Management profileNumber of profiles
Profiles2 records
Medigray funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medigray M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medigray
What does Medigray do?
Medigray is a Costa Rican pharmaceutical manufacturer that develops, produces, and commercializes a portfolio of more than 60 differentiated medications and cosmetics across therapeutic categories including respiratory, pain, dermatology, gastrointestinal, antiparasitic, cardiometabolic, urological, vascular, and high-level disinfection. Products are sold through direct institutional sales to the CCSS public healthcare system, pharmacy retail networks in Costa Rica, and export distribution to four additional countries in Central America and the Caribbean.
Is Medigray a public or private company?
Medigray is a private company. It is classified as family owned and is currently operating.
When was Medigray founded?
Medigray was founded in 1988. It employs 51 to 100 people.
Where is Medigray based?
Medigray is headquartered in Desamparados, Costa Rica, in the Latin America region.
How does Medigray make money?
One revenue line is on record: pharmaceutical Product Sales.
Who are Medigray's main competitors?
Direct peers on record are Eurofarma Laboratórios, Procaps S.A., Laboratorios Asofarma, Genomma Lab Internacional and Laboratorios Roemmers. Broad incumbents are Sanofi, Pfizer, Bayer and Teva Pharmaceutical Industries. Farmindustria S.A. is listed as a regional player.
Does Medigray have an API?
No public API is recorded for Medigray.
What industry is Medigray in?
Medigray's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.